LMB-100 is a is an antibody-toxin conjugate with an antimesothelin Fab linked to a 24-kilodalton portion of Pseudomonas exotoxin A with mutations that decrease immunogenicity.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.